z-logo
open-access-imgOpen Access
Hepatitis C in infection with recombinant strain RF2k/1b of the virus: clinical course and therapy
Author(s) -
Л. И. Николаева,
Г. В. Сапронов,
А.В. Колотвин,
Е И Самохвалов,
Elena Leybman,
L М Samokhodskaya
Publication year - 2014
Publication title -
èpidemiologiâ i infekcionnye bolezni
Language(s) - English
Resource type - Journals
eISSN - 2411-3026
pISSN - 1560-9529
DOI - 10.17816/eid40805
Subject(s) - recombinant dna , virology , medicine , virus , hepatitis c virus , antiviral therapy , russian federation , strain (injury) , chronic hepatitis , hepatitis , biology , biochemistry , gene , business , economic policy
Intergenotype recombinant RF2k/1b of hepatitis C virus was firstly detected in 2002 in the Russian Federation. In our study patients, infected with this recombinant, had high indices of liver fibrosis and did not achieve a sustained viral response to standard double therapy with exception of one participant. There are discussed and proposed options for treatment and diagnosis of these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here